Joanne M. Donovan, CMO at Edgewise Therapeutics, Inc. (EWTX), sold 32,716 shares at $30.98 ($1.0M) on 2026-03-27, disclosed to the SEC on 2026-03-30.
Open-market sale of $1.0M EWTX by CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.98 | 6,735 | $209K | 20.6% |
| 2 | $30.98 | 9,623 | $298K | 29.4% |
| 3 | $30.98 | 6,735 | $209K | 20.6% |
| 4 | $30.98 | 9,623 | $298K | 29.4% |
| Total | $30.98 avg | 32,716 | $1.0M | 100% |
| Filing → |
| EWTX | SELL | 2026-04-02 | $926K | — | Filing → |
| EWTX | SELL | 2026-03-31 | $1.4M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $38K | — | Filing → |